Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Can multiple sclerosis be diagnosed on a first demyelinating event?].

J de Seze1

  • 1Clinique neurologique hôpital Roger Salengro 59037 Lille. j-deseze@chru-lille.fr

Presse Medicale (Paris, France : 1983)
|March 19, 2004
PubMed
Summary

New criteria for diagnosing multiple sclerosis (MS) now incorporate magnetic resonance imaging (MRI) to enable earlier detection after a single episode. This aids in identifying high-risk patients and refining differential diagnoses for timely treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Criteria for the use of plasmapheresesis in optic neuritis: A practice review from French expert centers.

Revue neurologique·2025
Same author

Teriflunomide, cognition and MRI: A longitudinal study.

Multiple sclerosis and related disorders·2024
Same author

Clinical applications of deep learning in neuroinflammatory diseases: A scoping review.

Revue neurologique·2024
Same author

A decade of fingolimod in multiple sclerosis: Insights from a large real-world cohort study.

Revue neurologique·2023
Same author

Reverse Takotsubo cardiomyopathy as a complication of MOG-antibody-associated disease (MOGAD)? A case report.

Revue neurologique·2022

Area of Science:

  • Neurology
  • Immunology

Background:

  • Multiple sclerosis (MS) diagnosis traditionally required two distinct neurological episodes in different locations.
  • The advent of disease-modifying therapies necessitates updated diagnostic criteria.

Purpose of the Study:

  • To present revised diagnostic criteria for MS, allowing diagnosis after a single demyelinating episode.
  • To identify clinical and paraclinical predictors for MS and progressive MS.
  • To discuss differential diagnoses and the implications of early diagnosis and treatment.

Main Methods:

  • Review of recently proposed expert criteria for MS diagnosis.
  • Analysis of clinical and paraclinical factors predictive of MS progression.
  • Evaluation of differential diagnoses relevant to MS.

Related Experiment Videos

  • Assessment of the practical impact of early MS diagnosis.

    • Main Results:

    • Revised criteria emphasize magnetic resonance imaging (MRI) for diagnosing MS after the first clinical event.
    • Identification of predictive elements for disease progression.
    • Importance of comprehensive differential diagnosis to prevent misinitiation of treatment.

    Conclusions:

    • Updated criteria facilitate earlier MS diagnosis, particularly with MRI integration.
    • Early identification of high-risk patients is crucial for appropriate therapeutic decisions.
    • Thorough differential diagnosis is essential to avoid incorrect treatment initiation.